Ilene Wiggins, RN

CRS:

JHU

Role:

Clinical

Position:

Senior Research Nurse Program Manager for the Johns Hopkins CTU

Email:

iwiggin1@jhmi.edu

As CTU/CRS Coordinator/Research Manager, Ms. Wiggins is responsible for the day-to-day operations of the CTU with respect to domestic (U.S.) research activities. Ms. Wiggins has been a nurse coordinator for the Johns Hopkins AIDS Clinical Trials Unit (ACTU) for more than 20 years, and has been Research Manager/Coordinator for this Unit since 2002. In this role, she works closely with the PI’s, CRS Leaders and investigators to plan and execute the CTU’s scientific activities.

  • Chair, Site Management and Clinical Care Committee (Dec 2016)
  • SMCCC Representative, Protocol Development and implementation Subcommittee of the SMCCC (Dec 2015)
  • SMCCC Representative, Site Operations Subcommittee of the SMCCC (Dec 2016)
  • SMCCC Representative, Training and Education Working Group of the SOS (Dec 2015)
  • Member, Study Coordinators Working Group of the SOS (Jun 2011)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

P2026: Pharmacokinetic Properties of Antiretroviral and...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

Read More

A5332: Randomized Trial to Prevent Vascular Events in HIV...

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More